TRB Chemedica   Report issue

For profit Phase 2 Phase 3
Founded: Geneva Switzerland (1980)

Organization Overview

First Clinical Trial
2009
NCT01267214
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

TRB Chemedica | TRB Chemedica International SA